World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
104
Citations
68395
World Ranking
6891
National Ranking
3635

Overview

Maura L. Gillison is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily falls within the field of medicine, with a significant focus on oncology.

Their work addresses several subfields, including:

  • Oncology
  • Otorhinolaryngology
  • Molecular Biology
  • Pulmonary and Respiratory Medicine
  • Surgery

Gillison's main research topics include:

  • Head and Neck Cancer Studies
  • Cancer Immunotherapy and Biomarkers
  • Cervical Cancer and HPV Research
  • Lung Cancer Treatments and Mutations
  • Colorectal and Anal Carcinomas
  • Lung Cancer Research Studies
  • CAR-T cell therapy research

The scientist has contributed to multiple papers, including recent notable publications such as:

  • Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology (2020), Journal of the National Comprehensive Cancer Network
  • NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022 (2022), Journal of the National Comprehensive Cancer Network
  • Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance (2023), Nature Medicine
  • Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002) (2021), Journal of Clinical Oncology
  • Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States (2023), Journal of Clinical Oncology

Frequent co-authors in their work include:

  • Weihong Xiao
  • Neil D. Gross
  • Bo Jiang
  • Jimmy J. Caudell
  • Adam S. Garden

Gillison's research has appeared most frequently in the following publication venues:

  • Journal of Clinical Oncology
  • International Journal of Radiation Oncology*Biology*Physics
  • Regular and Young Investigator Award Abstracts
  • Annals of Oncology
  • Clinical Cancer Research

Best Publications

  • Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer

    K Kian Ang;Jonathan Harris;Richard Wheeler;Randal Weber

  • Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

    Robert L. Ferris;George Blumenschein;Jerome Fayette;Joel Guigay

  • Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States

    Anil K. Chaturvedi;Eric A. Engels;Ruth M. Pfeiffer;Brenda Y. Hernandez

  • Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers

    Maura Gillison;Wayne M. Koch;Randolph B. Capone;Michael Spafford

  • Case-control study of human papillomavirus and oropharyngeal cancer.

    Aimee R. Kreimer;Raphael Viscidi;Michael Pawlita;Carole Fakhry

  • Improved Survival of Patients With Human Papillomavirus–Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical Trial

    Carole Fakhry;William H. Westra;Sigui Li;Anthony Cmelak

  • Distinct Risk Factor Profiles for Human Papillomavirus Type 16–Positive and Human Papillomavirus Type 16–Negative Head and Neck Cancers

    Maura L. Gillison;Gypsyamber D'Souza;William Westra;Elizabeth Sugar

  • Incidence Trends for Human Papillomavirus–Related and –Unrelated Oral Squamous Cell Carcinomas in the United States

    Anil K. Chaturvedi;Eric A. Engels;William F. Anderson;Maura L. Gillison

  • Worldwide Trends in Incidence Rates for Oral Cavity and Oropharyngeal Cancers

    Anil K. Chaturvedi;William F. Anderson;Joannie Lortet-Tieulent;Maria Paula Curado

  • Prevalence of oral HPV infection in the United States, 2009-2010.

    Maura L. Gillison;Tatevik Broutian;Robert K. L. Pickard;Zhen-yue Tong

  • Epidemiology of Human Papillomavirus–Positive Head and Neck Squamous Cell Carcinoma

    Maura L. Gillison;Anil K. Chaturvedi;William F. Anderson;Carole Fakhry

  • Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial

    Maura L Gillison;Andy M Trotti;Jonathan Harris;Avraham Eisbruch

  • Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.

    David G. Pfister;Sharon Spencer;David Adelstein;Douglas Adkins

  • Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522

    K. Kian Ang;Qiang Zhang;David I. Rosenthal;Phuc Felix Nguyen-Tan

  • Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression.

    Robert L. Ferris;George Blumenschein;Jerome Fayette;Joel Guigay

  • Oral Sexual Behaviors Associated with Prevalent Oral Human Papillomavirus Infection

    Gypsyamber D’Souza;Yuri Agrawal;Jane Halpern;Sacared Bodison

  • Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity.

    Maura L. Gillison

  • Comprehensive control of human papillomavirus infections and related diseases.

    F. Xavier Bosch;Thomas R. Broker;David Forman;Anna Barbara Moscicki

  • HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women.

    Maura L. Gillison;Anil K. Chaturvedi;Douglas R. Lowy

  • Head and Neck Cancers, Version 2.2014

    David G. Pfister;Sharon Spencer;David M. Brizel;Barbara Burtness

Frequent Co-Authors

Robert I. Haddad
Robert I. Haddad Harvard University
Robert L. Ferris
Robert L. Ferris University of Pittsburgh
William H. Westra
William H. Westra Icahn School of Medicine at Mount Sinai
David I. Rosenthal
David I. Rosenthal The University of Texas MD Anderson Cancer Center
Randal S. Weber
Randal S. Weber The University of Texas MD Anderson Cancer Center
Kevin J. Harrington
Kevin J. Harrington Royal Marsden NHS Foundation Trust
Arlene A. Forastiere
Arlene A. Forastiere Johns Hopkins University
K. Kian Ang
K. Kian Ang The University of Texas MD Anderson Cancer Center
Quynh-Thu Le
Quynh-Thu Le Stanford University
Joseph A. Califano
Joseph A. Califano University of California, San Diego

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're interested in pursuing a career in medicine or healthcare but exploring flexible options, there are several pharmacy degree online programs available. These programs allow you to study at your own pace while preparing for a professional role in pharmacy, making them ideal for those balancing work or family commitments.

For those drawn to healthcare administration and technology, earning a him associate degree online offers entry into the growing field of health information management. This pathway focuses on managing patient health records, privacy, and the effective use of health data.

Many students also consider billing and coding classes online to quickly start a career in healthcare administration. These courses prepare you for vital positions in medical offices, clinics, and hospitals, handling essential documentation and insurance processes.

Aspiring advanced practice nurses will benefit from exploring the cheapest online fnp programs, which lead to a rewarding nurse practitioner career. These affordable programs help you advance your nursing education and expand your clinical skills while accommodating your current schedule.

Best Scientists Citing Maura L. Gillison

Trending Scientists